Citigroup, BofA Reportedly Exit UN's Net-Zero Banking Alliance

MT Newswires26minutes ago

A crisis is approaching! Wall Street's major firms face strong rivals in Trade, as electronic market makers may rise to prominence.

Traditional Wall Street major firms are facing an impending crisis. In 2025, they will notice that electronic market makers in Trade are behaving more and more like Banks.

Zhitong Finance03:03 ET

Citigroup Inc. (NYSE:C) Is Largely Controlled by Institutional Shareholders Who Own 73% of the Company

Yahoo FinanceJan 1 06:00 ET

Citigroup Unusual Options Activity

BenzingaDec 31 12:00 ET

Citi: Maintain Buy rating on KEYMED BIO-B with a Target Price of 60 Hong Kong dollars.

Citi released a research report stating that KEYMED BIO-B (02162) is undervalued, and its further progress in commercialization as well as the launch of new candidate drugs will prompt investors to reassess its value. Therefore, it maintains a "Buy/High Risk" rating with a Target Price of HKD 60. Recently, the weakness in KEYMED's stock price has fully reflected the 40% price cut of Dupixent in negotiations with the national medical insurance catalog, exceeding the market expectation of 30%, as well as investors' concerns about the commercialization prospects. KEYMED's management previously expressed confidence in a sales target of 0.5 billion RMB for 2025, with 60% planned.

Sina Hong Kong Stock.Dec 31, 2024 04:32 ET

Citibank: maintains XINYI SOLAR's "Neutral" rating, lowering the Target Price to 3.1 Hong Kong dollars.

Citi released a research report maintaining a "neutral" rating on XINYI SOLAR (00968), focusing on the losses in Photovoltaic Glass windows due to weak market demand. However, its financial status remains robust, with a forecast for lower capital expenditure budgets next year. The Target Price has been lowered by 14% to HKD 3.10 to reflect the adjusted earnings forecast. The firm indicated a downward adjustment of 11% to 18% in its Net income projections for XINYI SOLAR from this year through 2026, mainly reflecting a reduction in Photovoltaic Glass sales forecasts. The firm also assumes a year-on-year increase in glass production capacity of 14% and 4.5% over the next two years, impacted by additional capacity closures and postponed new projects. The firm's profit forecast for the company this year suggests.

Sina Hong Kong stocksDec 30, 2024 22:49 ET